Hospital do Coracao   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Sao Paulo Brazil (1918)

Organization Overview

First Clinical Trial
2008
NCT00736866
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital do Coracao | Instito do Coracao-HCFMUSP | Institute Director | Research Coordinator

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Acute Kidney Injury (Phase 3)

Acute Lung Injury (Phase 3)

Aneurysm (Phase 3)

Aortic Aneurysm (Phase 3)

Atrial Fibrillation (Phase 2)

Cardiovascular Diseases (Phase 3)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Coronavirus Infections (Phase 4)

Critical Illness (Phase 3)

Epilepsy (Phase 3)

Heart Diseases (Phase 3)

Heart Valve Diseases (Phase 2)

Infarction (Phase 3)

Infections (Phase 3)

Ischemia (Phase 3)

Kidney Diseases (Phase 3)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Peripheral Arterial Disease (Phase 3)

Peripheral Vascular Diseases (Phase 3)

Pneumonia (Phase 3)

Pneumonia, Viral (Phase 3)

Renal Insufficiency (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Severe Acute Respiratory Syndrome (Phase 4)

ST Elevation Myocardial Infarction (Phase 3)

Syndrome (Phase 4)

Vascular Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 24
  • # of Trial APIs: 30